-+ 0.00%
-+ 0.00%
-+ 0.00%

Standard BioTools Q4 Earnings Report: What Investors Need to Know

Benzinga·02/24/2026 21:17:17
Listen to the news

Standard BioTools (NASDAQ:LAB) released its Q4 earnings on Tuesday, February 24, 2026 at 04:10 PM.

Here's what's important from the earnings announcement.

Earnings

Standard BioTools beat estimated earnings by 225.0%, reporting an EPS of $0.05 versus an estimate of $-0.04.

Revenue was down $22.92 million from the same period last year.

Previous Earnings Records

In the previous quarter, the company missed on EPS by $0.05, resulting in a 4.2% drop change in the share price the following day.

Here's a look at Standard BioTools's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.04 -0.05 -0.04 -0.03
EPS Actual -0.09 -0.09 -0.07 -0.09
Revenue Estimate 18.00M 39.83M 40.10M 43.03M
Revenue Actual 19.55M 41.96M 40.80M 46.72M

To track all earnings releases for Standard BioTools visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.